Saxenda vs Ozempic South Africa: Which GLP-1 Injection Is Right for You?

Two names dominate the weight loss injection conversation in South Africa right now: Saxenda and Ozempic. Both are GLP-1 receptor agonists — injectable drugs that mimic a gut hormone to suppress appetite and slow stomach emptying. But they use different active ingredients, come at different price points, and suit different people. This guide gives you a straight side-by-side so you can have an informed conversation with your doctor.

Quick summary: Saxenda (liraglutide) is the only one of the two officially registered for weight loss in South Africa. Ozempic (semaglutide) is registered for type 2 diabetes but is widely prescribed off-label for weight management. Neither is cheap — and both require a doctor's script.

The Key Difference: Liraglutide vs Semaglutide

Saxenda's active ingredient is liraglutide. Ozempic's is semaglutide. Both are synthetic versions of GLP-1, the gut hormone released after eating. Both bind to GLP-1 receptors in the brain and gut to reduce hunger, slow digestion, and help you eat less without feeling deprived.

The structural difference matters more than it sounds. Semaglutide is longer-acting than liraglutide — which is why Ozempic only needs to be injected once a week, while Saxenda requires a daily injection. Clinical trials have also shown semaglutide produces greater average weight loss than liraglutide at equivalent stages of treatment.

Head-to-Head Comparison Table

Cost estimates are approximate 2026 private-market prices. Confirm with your pharmacy or doctor.

Weight Loss Results: What the Trials Show

Both drugs produce clinically meaningful weight loss when combined with a reduced-calorie diet and exercise — but semaglutide consistently outperforms liraglutide in head-to-head data.

• Saxenda SCALE trial (2015): Participants lost an average of 8.4 kg over 56 weeks versus 2.8 kg on placebo — roughly a 5–8% reduction in body weight.
• Ozempic STEP 1 trial (2021): Average weight loss of 14.9% of body weight at 68 weeks — nearly double Saxenda's result at a comparable timeframe.
• Direct comparison (STEP 8, 2022): Head-to-head, semaglutide 2.4 mg (Wegovy dose) produced 15.8% weight loss versus 6.4% for liraglutide 3 mg (Saxenda dose) over 68 weeks.

For context: if you weigh 100 kg, Saxenda might help you lose 5–8 kg; Ozempic at higher doses can push that to 13–16 kg. That difference is clinically significant, especially for people managing diabetes, NAFLD, or insulin resistance.

Side Effects: Are They Different?

The side effect profiles are broadly similar because both drugs work through the same GLP-1 mechanism. The most common issues affect the gut:

• Nausea (most common, especially in the first 4–8 weeks)
• Vomiting
• Diarrhoea or constipation
• Reduced appetite (the intended effect, but can feel unpleasant)
• Fatigue, particularly early on

Both drugs use a gradual dose-escalation protocol to minimise these effects. With Saxenda you start at 0.6 mg daily and increase weekly. With Ozempic you start at 0.25 mg weekly and step up monthly. In practice, Ozempic's once-weekly injection means fewer injections and slightly easier dose control for many patients.

A key contraindication for both: a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia type 2 (MEN 2). This is a hard stop — not just a caution.

Cost in South Africa: What You Will Actually Pay

Both drugs are expensive — and most South Africans pay out of pocket, since medical aid coverage for weight loss is limited. Here is the practical picture:

• Saxenda: Typically R3,000–R5,000 per month at full maintenance dose (3 mg/day). The dose-escalation phase costs less in the first few weeks.
• Ozempic: R2,500–R4,500 per month depending on dose (0.5 mg or 1 mg pens). Note: Ozempic is prescribed off-label for weight loss in SA — some doctors prescribe 0.5–1 mg rather than the higher Wegovy 2.4 mg dose, partly due to cost and availability.
• Wegovy (semaglutide 2.4 mg, registered specifically for weight loss): availability in SA is limited and intermittent. When available, expect R4,000–R6,000+ per month. See our Wegovy SA pricing guide for the latest.

Over 12 months, you are looking at R36,000–R60,000 for either drug at full dose. This is why diet and lifestyle changes remain the foundation — see our Ozempic diet plan guide for how to maximise results while on GLP-1 medication.

Which One Should You Ask Your Doctor About?

There is no universally "better" drug — it depends on your situation. Here is a practical guide:

Consider Saxenda if:

• You have obesity (BMI ≥30) without type 2 diabetes
• You prefer a drug officially registered for weight loss in SA (on-label comfort)
• You want daily injection flexibility (easier to miss one dose without disrupting weekly timing)
• Your medical aid covers Saxenda via a managed care programme

Consider Ozempic if:

• You have type 2 diabetes alongside obesity — Ozempic is its registered indication
• You want a once-weekly injection rather than daily
• Higher weight loss potential is a priority
• You are already using Metformin or other diabetes drugs and want to consolidate

Consider Mounjaro (tirzepatide) if:

• You want the strongest weight loss data currently available — tirzepatide targets both GLP-1 and GIP receptors
• Average weight loss in trials exceeded 20% body weight at higher doses
• See our full Mounjaro South Africa guide for cost and availability

Availability in South Africa

Both Saxenda and Ozempic have experienced periodic stock shortages in South Africa since 2023, driven by global demand for GLP-1 drugs. The situation has improved in 2026 but availability can still vary by pharmacy and region.

• Saxenda is manufactured by Novo Nordisk and is the most consistently stocked weight loss injection at major SA pharmacy chains (Dis-Chem, Clicks, independent compounding pharmacies).
• Ozempic stock has been more variable — demand from people using it off-label for weight loss created shortages that affected diabetic patients. Stock has largely stabilised at 0.5 mg and 1 mg doses.
• Always confirm stock before booking a doctor's appointment to get the script. A script for Ozempic that expires while you wait for stock is a frustrating and expensive waste.

What About Generic Semaglutide?

Generic semaglutide has entered the SA market — but buyer beware. See our detailed guide on generic semaglutide in South Africa for what is legitimate, what to avoid, and how to verify your source. There is no approved generic liraglutide (Saxenda) in SA at this time.

Supporting Your Injection with Diet

GLP-1 drugs work best when paired with a calorie-appropriate, protein-rich diet. The appetite suppression these drugs produce can be dramatic — some patients struggle to eat enough protein, which risks muscle loss alongside fat loss. Key principles:

• Prioritise protein at every meal — biltong, eggs, chicken, legumes, tinned pilchards
• Avoid ultra-processed foods even when appetite is low — quality matters more than quantity on GLP-1s
• Stay hydrated: nausea often worsens with dehydration
• Small, frequent meals beat three large meals for managing GI side effects
• Rooibos tea (caffeine-free) is a good low-calorie option for between meals

For a full eating plan, see our foods to avoid on Ozempic guide and the broader Saxenda SA guide.

The Bottom Line

If you are choosing purely on weight loss results, semaglutide (Ozempic/Wegovy) has stronger clinical data than liraglutide (Saxenda) at every comparable dose. If you want an on-label, SA-registered weight loss drug with a well-established local track record, Saxenda is the cleaner choice. If you have type 2 diabetes, Ozempic is the natural fit.

Neither drug is a magic fix. Both work best as part of a broader lifestyle change — and both are expensive enough that you want to make every rand count by optimising your diet and activity alongside the injection. Talk to your GP or an obesity medicine specialist for a personalised recommendation.